{"pmid":32448757,"title":"The Iranian Society of Echocardiography (ISE) Statement on Performing Echocardiography During the COVID-19 Pandemic.","text":["The Iranian Society of Echocardiography (ISE) Statement on Performing Echocardiography During the COVID-19 Pandemic.","Corona virus disease 2019(COVID-19) pandemic has caused a significant burden on the global health system. Considerable cardiovascular involvement has been reported among COVID-19 patients with higher ICU admission and mortality rates among patients with cardiovascular comorbidities. Consequently, diagnostic cardiovascular evaluations such as echocardiography are a crucial part of the disease management. On the other hand, providing safety for the patients and the healthcare personnel is a matter of great concern in the pandemic state. In this document, we have provided recommendations on performing echocardiography in hospital echocardiography labs and outpatient echocardiography clinics during the current COVID-19 (Coronavirus disease of 2019) outbreak.","Curr Probl Cardiol","Sattarzadeh Badkoubeh, Roya","Almassi, Nooshin","Moshkani Farahani, Maryam","Movassaghi, Naser","Khosravi, Arezoo","Mirdamadi, Ahmad","Kamali, Monireh","Manshouri, Shirin","Toufan Tabrizi, Mehrnoush","Farrashi, Melody","Samiei, Niloufar","32448757"],"abstract":["Corona virus disease 2019(COVID-19) pandemic has caused a significant burden on the global health system. Considerable cardiovascular involvement has been reported among COVID-19 patients with higher ICU admission and mortality rates among patients with cardiovascular comorbidities. Consequently, diagnostic cardiovascular evaluations such as echocardiography are a crucial part of the disease management. On the other hand, providing safety for the patients and the healthcare personnel is a matter of great concern in the pandemic state. In this document, we have provided recommendations on performing echocardiography in hospital echocardiography labs and outpatient echocardiography clinics during the current COVID-19 (Coronavirus disease of 2019) outbreak."],"journal":"Curr Probl Cardiol","authors":["Sattarzadeh Badkoubeh, Roya","Almassi, Nooshin","Moshkani Farahani, Maryam","Movassaghi, Naser","Khosravi, Arezoo","Mirdamadi, Ahmad","Kamali, Monireh","Manshouri, Shirin","Toufan Tabrizi, Mehrnoush","Farrashi, Melody","Samiei, Niloufar"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448757","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.cpcardiol.2020.100620","topics":["Prevention"],"weight":1,"_version_":1667785213901537282,"score":9.490897,"similar":[{"pmid":32241097,"title":"Echocardiography during the coronavirus disease 2019 (COVID-19) pandemic: expert opinion of the Working Group on Echocardiography of the Polish Cardiac Society.","text":["Echocardiography during the coronavirus disease 2019 (COVID-19) pandemic: expert opinion of the Working Group on Echocardiography of the Polish Cardiac Society.","Transthoracic and transesophageal echocardiography may be required in patients with coronavirus disease 2019 (COVID19), resulting in direct contact with the patient and risk of transmitting the infection from patients to medical personnel. Therefore, we recommend to perform problemoriented timelimited transthoracic examinations. Whenever possible, examinations should be analyzed offline, outside the isolation zones. Transesophageal echocardiography is considered an aerosolgenerating procedure and should be performed only as a lifesaving procedure. Personnel should use appropriate personal protection equipment in the immediate vicinity of the patients in accordance with the relevant guidelines.","Kardiol Pol","Gackowski, Andrzej","Lipczynska, Magdalena","Lipiec, Piotr","Szymanski, Piotr","32241097"],"abstract":["Transthoracic and transesophageal echocardiography may be required in patients with coronavirus disease 2019 (COVID19), resulting in direct contact with the patient and risk of transmitting the infection from patients to medical personnel. Therefore, we recommend to perform problemoriented timelimited transthoracic examinations. Whenever possible, examinations should be analyzed offline, outside the isolation zones. Transesophageal echocardiography is considered an aerosolgenerating procedure and should be performed only as a lifesaving procedure. Personnel should use appropriate personal protection equipment in the immediate vicinity of the patients in accordance with the relevant guidelines."],"journal":"Kardiol Pol","authors":["Gackowski, Andrzej","Lipczynska, Magdalena","Lipiec, Piotr","Szymanski, Piotr"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241097","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.33963/KP.15265","locations":["Transthoracic"],"topics":["Prevention"],"weight":1,"_version_":1666138492161228800,"score":276.44977},{"pmid":32425014,"title":"The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact.","text":["The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact.","SARS-CoV-2 infection, responsible for COVID-19, can determine cardiac events, which require a quick diagnosis and management, and should not be overlooked due to the presence of COVID-19 infection. In some cases, cardiovascular symptoms can also be the first and only manifestation of SARS-CoV-2 infection. In patients with COVID-19, the full cardiovascular disease diagnostic algorithm can be hindered by logistic restrain mainly derived from the difficulty of transporting patients in critical conditions to Radiology or Hemodynamics wards. The echocardiography in SARS-CoV-2 pandemic can help for differential diagnosis of cardiac events, which can be related or unrelated by the infection and can likely impact on short-term prognosis. Indeed, transthoracic echocardiography plays a key role in the screen for CV complications of COVID-19 infection: it must be focused cardiac ultrasound study (FoCUS) performed at bedside. All transthoracic, transesophageal and stress echocardiograms in patients in which test results are unlikely to change the management strategy should be postponed.","Monaldi Arch Chest Dis","Pacileo, Mario","Giallauria, Francesco","Savarese, Cristina","Cirillo, Teresa","Crescibene, Fabio","Di Lorenzo, Anna","Ferrillo, Mariacarla","Calabrese, Maria Grazia","Vigorito, Carlo","D'Andrea, Antonello","32425014"],"abstract":["SARS-CoV-2 infection, responsible for COVID-19, can determine cardiac events, which require a quick diagnosis and management, and should not be overlooked due to the presence of COVID-19 infection. In some cases, cardiovascular symptoms can also be the first and only manifestation of SARS-CoV-2 infection. In patients with COVID-19, the full cardiovascular disease diagnostic algorithm can be hindered by logistic restrain mainly derived from the difficulty of transporting patients in critical conditions to Radiology or Hemodynamics wards. The echocardiography in SARS-CoV-2 pandemic can help for differential diagnosis of cardiac events, which can be related or unrelated by the infection and can likely impact on short-term prognosis. Indeed, transthoracic echocardiography plays a key role in the screen for CV complications of COVID-19 infection: it must be focused cardiac ultrasound study (FoCUS) performed at bedside. All transthoracic, transesophageal and stress echocardiograms in patients in which test results are unlikely to change the management strategy should be postponed."],"journal":"Monaldi Arch Chest Dis","authors":["Pacileo, Mario","Giallauria, Francesco","Savarese, Cristina","Cirillo, Teresa","Crescibene, Fabio","Di Lorenzo, Anna","Ferrillo, Mariacarla","Calabrese, Maria Grazia","Vigorito, Carlo","D'Andrea, Antonello"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425014","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.4081/monaldi.2020.1358","topics":["Prevention","Diagnosis"],"weight":1,"_version_":1667352728706220033,"score":258.06516},{"pmid":32503706,"title":"Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography.","text":["Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography.","BACKGROUND: Three cases of the application of focused cardiac ultrasound in patients with coronavirus disease 2019 are presented. METHODS: Cardiac point-of-care ultrasound, limited transthoracic echocardiography, and critical care echocardiography were applied in cases of heart failure, pulmonary embolism, and myocarditis with thrombus respectively. RESULTS: The impact on patient management and the global context of each presentation are discussed. CONCLUSIONS: Focused cardiac point-of-care ultrasound played an important, front-line role in the bedside management of patients during the COVID-19 pandemic in Wuhan, China.","J Am Soc Echocardiogr","Zhang, Li","Wang, Bin","Zhou, Jianhua","Kirkpatrick, James","Xie, Mingxing","Johri, Amer M","32503706"],"abstract":["BACKGROUND: Three cases of the application of focused cardiac ultrasound in patients with coronavirus disease 2019 are presented. METHODS: Cardiac point-of-care ultrasound, limited transthoracic echocardiography, and critical care echocardiography were applied in cases of heart failure, pulmonary embolism, and myocarditis with thrombus respectively. RESULTS: The impact on patient management and the global context of each presentation are discussed. CONCLUSIONS: Focused cardiac point-of-care ultrasound played an important, front-line role in the bedside management of patients during the COVID-19 pandemic in Wuhan, China."],"journal":"J Am Soc Echocardiogr","authors":["Zhang, Li","Wang, Bin","Zhou, Jianhua","Kirkpatrick, James","Xie, Mingxing","Johri, Amer M"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503706","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.echo.2020.04.004","keywords":["covid-19 infection","critical care echocardiography","focused cardiac ultrasound","limited transthoracic echocardiography","point-of-care ultrasound"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1668892488266416128,"score":234.70149},{"pmid":32415767,"title":"Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","text":["Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services.","Kardiol Pol","Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D","32415767"],"abstract":["Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services."],"journal":"Kardiol Pol","authors":["Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415767","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.33963/KP.15358","locations":["Polish"],"countries":["Poland"],"countries_codes":["POL|Poland"],"topics":["Prevention"],"weight":1,"_version_":1666994545911398400,"score":201.12923},{"pmid":32503707,"title":"Echocardiography in Pandemic: Front-Line Perspective, Expanding Role of Ultrasound, and Ethics of Resource Allocation.","text":["Echocardiography in Pandemic: Front-Line Perspective, Expanding Role of Ultrasound, and Ethics of Resource Allocation.","The grave clinical context of the coronavirus disease 2019 (COVID-19) pandemic must be understood. Italy is immersed in the COVID-19 pandemic. Most of the world will soon follow. The United States currently has the most documented cases of COVID-19 of any nation. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-associated acute cardiomyopathy is common in critical care patients and is associated with a high mortality rate. Patients with COVID-19 frequently require mechanical support for adequate oxygenation. A severe shortfall of ventilators is predicted. Of equal concern is the projected shortage of trained professionals required to care for patients on mechanical ventilation. Ultrasonography is proving to be a valuable tool for identifying the pulmonary manifestations and progression of COVID-19. Lung ultrasound also facilitates successful weaning from mechanical ventilation. Ultrasonography of the lung, pleura, and diaphragm are easily mastered by experienced echocardiographers. Echocardiography has an established role for optimal fluid management and recognition of cardiac disease, including SARS-CoV-2-associated acute cardiomyopathy. Cardiologists, anesthesiologists, sonographers, and all providers should be prepared to commit their full spectrum of skills to mitigate the consequences of the pandemic. We should also be prepared to collaborate and cross-train to expand professional services as necessary. During a declared health care crisis, providers must be familiar with the ethical principles, organizational structure, practical application, and gravity of limited resource allocation.","J Am Soc Echocardiogr","Drake, Daniel H","De Bonis, Michele","Covella, Michele","Agricola, Eustachio","Zangrillo, Alberto","Zimmerman, Karen G","Cobey, Frederick C","32503707"],"abstract":["The grave clinical context of the coronavirus disease 2019 (COVID-19) pandemic must be understood. Italy is immersed in the COVID-19 pandemic. Most of the world will soon follow. The United States currently has the most documented cases of COVID-19 of any nation. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-associated acute cardiomyopathy is common in critical care patients and is associated with a high mortality rate. Patients with COVID-19 frequently require mechanical support for adequate oxygenation. A severe shortfall of ventilators is predicted. Of equal concern is the projected shortage of trained professionals required to care for patients on mechanical ventilation. Ultrasonography is proving to be a valuable tool for identifying the pulmonary manifestations and progression of COVID-19. Lung ultrasound also facilitates successful weaning from mechanical ventilation. Ultrasonography of the lung, pleura, and diaphragm are easily mastered by experienced echocardiographers. Echocardiography has an established role for optimal fluid management and recognition of cardiac disease, including SARS-CoV-2-associated acute cardiomyopathy. Cardiologists, anesthesiologists, sonographers, and all providers should be prepared to commit their full spectrum of skills to mitigate the consequences of the pandemic. We should also be prepared to collaborate and cross-train to expand professional services as necessary. During a declared health care crisis, providers must be familiar with the ethical principles, organizational structure, practical application, and gravity of limited resource allocation."],"journal":"J Am Soc Echocardiogr","authors":["Drake, Daniel H","De Bonis, Michele","Covella, Michele","Agricola, Eustachio","Zangrillo, Alberto","Zimmerman, Karen G","Cobey, Frederick C"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503707","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.echo.2020.04.007","keywords":["echocardiography","mechanical","pandemics","resource allocation","ultrasonography","ventilators"],"locations":["Italy","United States"],"countries":["Italy","United States"],"countries_codes":["ITA|Italy","USA|United States"],"weight":0,"_version_":1668892488260124672,"score":199.24538}]}